Essential signaling in NF2 loss-related tumours: the therapeutic potential of CRL4^DCAF1 and mTOR combined inhibition

J Thorac Dis. 2017 Oct;9(10):3533-3536. doi: 10.21037/jtd.2017.09.34.

Authors

Helena J Janse van Rensburg¹, Xiaolong Yang¹

Affiliation

¹ Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, K7L 3N6, Canada.

No abstract available

Publication types

Editorial
Comment